Suppr超能文献

相似文献

3
Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.
Behav Res Ther. 2018 Aug;107:34-41. doi: 10.1016/j.brat.2018.05.010. Epub 2018 May 24.
4
Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.
Arch Gen Psychiatry. 2011 Apr;68(4):378-88. doi: 10.1001/archgenpsychiatry.2011.25.
5
Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care.
Psychol Med. 2012 Sep;42(9):1937-48. doi: 10.1017/S0033291711002893. Epub 2011 Dec 13.
7
Evaluation of an integrated group cognitive-behavioral treatment for comorbid mood, anxiety, and substance use disorders: A pilot study.
J Anxiety Disord. 2017 Mar;46:85-100. doi: 10.1016/j.janxdis.2016.08.002. Epub 2016 Aug 20.
8
Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial.
Drug Alcohol Depend. 2019 Apr 1;197:28-36. doi: 10.1016/j.drugalcdep.2018.12.023. Epub 2019 Feb 5.
10
Treatment of co-occurring anxiety disorders and substance use disorders.
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):99-111. doi: 10.1097/HRP.0000000000000058.

引用本文的文献

1
Feasibility in Community Mental Health Research: A Scoping Review.
Adm Policy Ment Health. 2025 Jun 29. doi: 10.1007/s10488-025-01457-8.
3
A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders.
J Subst Use Addict Treat. 2024 Oct;165:209442. doi: 10.1016/j.josat.2024.209442. Epub 2024 Jun 16.
5
A Transdiagnostic group therapy for sleep and anxiety among adults with substance use disorders: Protocol and pilot investigation.
Front Psychiatry. 2023 Mar 29;14:1160001. doi: 10.3389/fpsyt.2023.1160001. eCollection 2023.
6
The Role of Affect in Psychosocial Treatments for Substance Use Disorders.
Curr Addict Rep. 2020 Jun;7(2):108-116. doi: 10.1007/s40429-020-00304-0. Epub 2020 Jun 1.
8
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies.
J Addict Med. 2020 Dec;14(6):e293-e296. doi: 10.1097/ADM.0000000000000755.
10
Integrating Treatment for Co-Occurring Mental Health Conditions.
Alcohol Res. 2019 Jan 1;40(1). doi: 10.35946/arcr.v40.1.07. eCollection 2019 Oct 24.

本文引用的文献

2
Direct-to-consumer marketing of evidence-based psychological interventions: introduction.
Behav Ther. 2012 Jun;43(2):231-5. doi: 10.1016/j.beth.2011.07.003. Epub 2011 Jul 28.
3
Understanding and treating comorbid anxiety disorders in substance users: review and future directions.
J Addict Med. 2011 Dec;5(4):233-47. doi: 10.1097/ADM.0b013e31823276d7.
4
Moving beyond parity--mental health and addiction care under the ACA.
N Engl J Med. 2011 Sep 15;365(11):973-5. doi: 10.1056/NEJMp1108649. Epub 2011 Aug 17.
5
Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning.
Am J Addict. 2010 Sep-Oct;19(5):385-90. doi: 10.1111/j.1521-0391.2010.00061.x.
8
Treatment for anxiety disorders: Efficacy to effectiveness to implementation.
Behav Res Ther. 2009 Nov;47(11):931-7. doi: 10.1016/j.brat.2009.07.012. Epub 2009 Jul 14.
9
10
Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).
J Affect Disord. 2009 Jan;112(1-3):92-101. doi: 10.1016/j.jad.2008.03.014. Epub 2008 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验